Limit tests acc. to Ph. Eur. 2.04, USP and JP

Testing of raw materials, excipients, APIs in the frame of release analytics

Therapeutic Modalities:

Small Molecules

Development Phases:

Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

EP 2.04